Strategic Focus Nova Leah is a world leader in cybersecurity risk management for medical devices and healthcare providers, with a newly launched SelectEvaluate platform for third party risk management and continuous monitoring. This presents an opportunity to position additional integration and professional services around third-party vendor risk assessments, monitoring coverage, and compliance workflows for mid to large healthcare organizations.

Strong Investment Backing The company has secured notable funding, including seed investment led by Northwell Health Ventures and multiple prior rounds, signaling validated market potential and credibility with health system buyers. Leverage this to engage health networks and risk management teams that prioritize proven, scalable solutions.

Expansion Footprint With offices in Dundalk and the United States and a clear product expansion into SelectEvaluate, Nova Leah is positioned to target cross-border healthcare organizations and U.S. health systems expanding third-party risk programs, offering partner-enabled sales and territory-focused outreach.

Awarded Credibility Historical recognition in Ireland’s startup ecosystem and export awards demonstrates credibility and momentum. Use this to build trust with potential customers and channels by highlighting track record, early customer wins, and industry recognition in initial outreach.

Tech Stack Enablement A modern technology stack including Jira, Confluence, Jenkins, and HubSpot indicates strong collaboration, workflows, and marketing automation capabilities. Propose packaged demonstrations of streamlined implementation, seamless integration with existing DevSecOps tooling, and scalable adoption for large healthcare networks.